Author:
Faries Douglas E,Ascher-Svanum Haya,Nyhuis Allen W,Kinon Bruce J
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health
Reference24 articles.
1. Hamer S, Haddad PM: Adverse effects of antipsychotics as outcome measures. Br J Psychiatry. 2007, 50 (Suppl): s64-s70. 10.1192/bjp.191.50.s64.
2. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005, 353: 1209-1223. 10.1056/NEJMoa051688.
3. Liu-Seifert H, Adams DH, Kinon BJ: Discontinuation of treatment of schizophrenia patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs. BMC Med. 2005, 3: 21-10.1186/1741-7015-3-21.
4. Dossenbach MR, Kratky P, Schneidman M, Grundy SL, Metcalfe S, Tollefson GD, Belmaker RH: Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone. J Clin Psychiatry. 2001, 62 (Suppl 2): 28-34.
5. McEvoy JP: The costs of schizophrenia. J Clin Psychiatry. 2007, 68 (Suppl 14): 4-7.
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献